The phosphatase inhibitor okadaic acid induces skin and gastrointestinal tract cancers, and four mutations in a PP2A subunit, Aα, identified in human tumors, have reduced PP2A function [12-14]. This evidence concerns the gene PTPA and digestive system cancer.